Aura Biosciences Insider Trades
NASDAQ: AURAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 11 · $39.95M
- Shares bought / sold
- 0 / 7.09M
- Net activity
- Net selling $39.9 million
Aura Biosciences insider activity
Over the last 12 months, Aura Biosciences insiders reported 30 transactions on SEC Form 4: 0 open-market purchases and 11 sales. Insiders bought $0 and sold $39.9 million worth of stock, for net insider selling of $39.9 million. The largest seller was Matrix Capital Management Company, LP & GOEL DAVID E., with $39.0 million in reported sales.
The most recent filing shows Hopkins Janet Jill (Chief Medical Officer) selling 16,903 shares at $7.05 on Nov 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AURA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AURA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 16, 2026 | Hopkins Janet JillChief Medical Officer | Sale | 16,903 | $119.17K | Form 4 |
| Sep 1, 2026 | Abu-Absi SusanChief Operating Officer | Award | 134,513 | — | Form 4 |
| Sep 1, 2026 | Elazzouzi AmySVP, Finance & PAO | Award | 23,540 | — | Form 4 |
| Sep 1, 2026 | Hopkins Janet JillChief Medical Officer | Award | 58,850 | — | Form 4 |
| Sep 1, 2026 | Kratz EricaChief Reg. & Quality Officer | Award | 100,885 | — | Form 4 |
| Sep 1, 2026 | Person JulieChief People Officer | Award | 107,611 | — | Form 4 |
| Jul 7, 2026 | Bender JeremyDirector | Award | 30,000 | — | Form 4 |
| Jul 1, 2026 | Kilroy ConorSee Remarks | Award | 14,858 | — | Form 4 |
| Jun 16, 2026 | Gibney Anthony SSee Remarks | Sale | 12,824 | $82.33K | Form 4 |
| Jun 11, 2026 | Mattessich Antony C.Director | Award | 15,000 | — | Form 4 |
| Jun 11, 2026 | Johnson David MichaelDirector | Award | 15,000 | — | Form 4 |
| Jun 11, 2026 | Srivastava SapnaDirector | Award | 15,000 | — | Form 4 |
| Jun 11, 2026 | Bitetti Teresa MarieDirector | Award | 15,000 | — | Form 4 |
| May 19, 2026 | Holles Natalie C.See Remarks | Award | 553,844 | — | Form 4 |
| May 19, 2026 | Holles Natalie C.See Remarks | Award | 600,118 | — | Form 4 |
| May 7, 2026 | Matrix Capital Management Company, LP & GOEL DAVID E.10% Owner | Sale | 6,922,870 | $39.04M | Form 4 |
| Apr 16, 2026 | Kilroy ConorSee Remarks | Sale | 11,738 | $82.40K | Form 4 |
| Mar 2, 2026 | Plavsic MarkChief Technology Officer | Award | 62,339 | — | Form 4 |
| Mar 2, 2026 | Elazzouzi AmySenior Vice President, Finance | Award | 44,528 | — | Form 4 |
| Mar 2, 2026 | Hopkins Janet JillChief Medical Officer | Award | 89,056 | — | Form 4 |
| Mar 2, 2026 | de los Pinos ElisabetSee Remarks | Award | 166,000 | — | Form 4 |
| Mar 2, 2026 | Kilroy ConorSee Remarks | Award | 62,339 | — | Form 4 |
| Mar 2, 2026 | Gibney Anthony SSee Remarks | Award | 71,245 | — | Form 4 |
| Feb 17, 2026 | de los Pinos ElisabetSee Remarks | Sale | 47,648 | $241.10K | Form 4 |
| Feb 17, 2026 | Hopkins Janet JillChief Medical Officer | Sale | 20,401 | $103.23K | Form 4 |
| Feb 17, 2026 | Elazzouzi AmySenior Vice President, Finance | Sale | 8,549 | $43.26K | Form 4 |
| Feb 17, 2026 | Plavsic MarkChief Technology Officer | Sale | 15,890 | $80.24K | Form 4 |
| Feb 17, 2026 | Kilroy ConorSee Remarks | Sale | 12,079 | $61.00K | Form 4 |
| Jan 20, 2026 | Elazzouzi AmySenior Vice President, Finance | Sale | 1,581 | $7.68K | Form 4 |
| Jan 20, 2026 | de los Pinos ElisabetSee Remarks | Sale | 16,928 | $82.27K | Form 4 |
| Nov 17, 2025 | Hopkins Janet JillChief Medical Officer | Sale | 17,109 | $92.73K | Form 4 |
| Oct 29, 2025 | de los Pinos ElisabetSee Remarks | Sale | 9,049 | $57.46K | Form 4 |
| Oct 29, 2025 | Elazzouzi AmySenior Vice President, Finance | Sale | 896 | $5.69K | Form 4 |
| Oct 16, 2025 | Plavsic MarkChief Technology Officer | Sale | 12,169 | $77.27K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Sale | 7,722 | $51.74K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 2,319 | $9.86K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 1,094 | $3.46K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 4,744 | $13.00K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 547 | $2.85K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 547 | $3.00K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 1,094 | $6.00K | Form 4 |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance | Option exercise | 2,554 | $12.95K | Form 4 |
| Jun 17, 2025 | Mattessich Antony C.Director | Award | 13,000 | — | Form 4 |
| Jun 17, 2025 | Srivastava SapnaDirector | Award | 13,000 | — | Form 4 |
| Jun 17, 2025 | Johnson David MichaelDirector | Award | 13,000 | — | Form 4 |
| Jun 2, 2025 | de los Pinos ElisabetSee Remarks | Tax withholding | 9,948 | $61.28K | Form 4 |
| Jun 2, 2025 | de los Pinos ElisabetSee Remarks | Option exercise | 10,948 | $55.51K | Form 4 |
| Jun 2, 2025 | Gibney Anthony SSee Remarks | Award | 150,000 | — | Form 4 |
| May 16, 2025 | Gibney Anthony SSee Remarks | Sale | 1,519 | $7.82K | Form 4 |
| May 16, 2025 | Gibney Anthony SSee Remarks | Buy | 50,000 | $245.00K | Form 4 |
| May 16, 2025 | Johnson David MichaelDirector | Buy | 20,000 | $98.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4